Fevzi Yalniz is a Hematology physician affiliated with University of Kentucky HealthCare. OpenAlex indexes 105 publications with 1,094 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 Rose St Roach Cancer Ctr 1st Fl
Lexington, KY 405365505
Telephone
859-257-6006Provider last certified this registry record 23 Sept 2021.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medexus Pharma, Inc.Program year20251 payment
- GENZYME CORPORATIONProgram year20251 payment
- Stemline Therapeutics Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
29.8%Kinase inhibitor15.6%Bosulif24%Brukinsa23%Imatinib Mesylate16%Jakafi15%Tasigna14%Iclusig9%Part D<11 patientsBCL-2 Inhibitor6.6%Venclexta100%Part D≥17 patients+ 5 more classes in this area
Anti-infectives
21.9%Azole Antifungal5.3%Fluconazole62%Posaconazole38%Part D≥14 patientsFluoroquinolone Antibacterial4%Levofloxacin100%Part D≥17 patients+ 5 more classes in this area
Dermatology
18.9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor18.9%Acyclovir100%Part D≥47 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Islam Elgendy, MD
University of Kentucky HealthCare
Emma Birks, MD
University of Kentucky HealthCare
Justin Fraser, MD
University of Kentucky HealthCare
Emily Defranco, DO
University of Kentucky HealthCare
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”